ZA200803582B - 4-(3-Aminopyrazole) Pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer - Google Patents

4-(3-Aminopyrazole) Pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer

Info

Publication number
ZA200803582B
ZA200803582B ZA200803582A ZA200803582A ZA200803582B ZA 200803582 B ZA200803582 B ZA 200803582B ZA 200803582 A ZA200803582 A ZA 200803582A ZA 200803582 A ZA200803582 A ZA 200803582A ZA 200803582 B ZA200803582 B ZA 200803582B
Authority
ZA
South Africa
Prior art keywords
aminopyrazole
cancer
treatment
tyrosine kinase
kinase inhibitors
Prior art date
Application number
ZA200803582A
Inventor
Feng Xiaomei
Kan Ying
Peng Bo
Wang Bin
Zhang Hai-Jun
Guan Huiping
Loannidis Stephanos
Su Mei Wang Tao
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200803582B publication Critical patent/ZA200803582B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
ZA200803582A 2005-10-28 2008-04-23 4-(3-Aminopyrazole) Pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer ZA200803582B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73129905P 2005-10-28 2005-10-28

Publications (1)

Publication Number Publication Date
ZA200803582B true ZA200803582B (en) 2009-02-25

Family

ID=40247950

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200803582A ZA200803582B (en) 2005-10-28 2008-04-23 4-(3-Aminopyrazole) Pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer

Country Status (4)

Country Link
CN (1) CN101346371B (en)
SI (1) SI1945631T1 (en)
UA (1) UA95260C2 (en)
ZA (1) ZA200803582B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013033862A1 (en) * 2011-09-05 2013-03-14 浙江海正药业股份有限公司 4-substituted-(3-substituted-1h-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY141220A (en) * 2003-11-17 2010-03-31 Astrazeneca Ab Pyrazole derivatives as inhibitors of receptor tyrosine kinases

Also Published As

Publication number Publication date
SI1945631T1 (en) 2012-11-30
CN101346371B (en) 2012-11-14
UA95260C2 (en) 2011-07-25
CN101346371A (en) 2009-01-14

Similar Documents

Publication Publication Date Title
IL190935A0 (en) 4-(3-aminopyrazole)pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
IL186845A0 (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
IL174989A0 (en) 4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer
ZA200901593B (en) Pyrimidines derivatives and their use as kinase inhibitors
HK1104286A1 (en) Pyrimidine urea derivatives as kinase inhibitors
IL195152A0 (en) Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders
IL174258A0 (en) Quinazoline derivatives as tyrosine kinase inhibitors
IL174261A0 (en) Quinazoline derivatives as tyrosine kinase inhibitors
IL195731A0 (en) Pyrimidine derivatives useful in the treatment of cancer
IL177007A0 (en) 2-(3-substituted-aryl) amino-4-thiazoles as tyrosine kinase inhibitors
IL186381A0 (en) Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
IL173200A0 (en) Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors
IL207224A0 (en) Pyrrolo [2,3-d] pyrimidines and use thereof as tyrosine kinase inhibitors
PT2188289E (en) (7h-pyrrolo[2,3-d]pyrimidin-4-yl)-piperazines as kinase inhibitors for the treatment of cancer and inflammation
IL187895A0 (en) Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
IL184997A0 (en) Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis
IL185791A0 (en) Tyrosine kinase inhibitor compositions and methods for manufacturing and using them in the treatment of disease
IL184798A0 (en) Quinazoline derivatives as tyrosine kinase inhibitors
HK1120793A1 (en) 4- (ih-indazol-5-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer
ZA200608998B (en) Imidazole derivatives as tyrosine kinase inhibitors
EP1951252A4 (en) Tyrosine kinase inhibitors
ZA200902730B (en) Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
ZA200704735B (en) Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis
ZA200803582B (en) 4-(3-Aminopyrazole) Pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
ZA200603037B (en) 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer